Researchers developing vaccine candidates against COVID19 can benefit from TRANSVAC2 services
The European vaccine infrastructure TRANSVAC2, coordinated by European Vaccine Initiative, offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. Any target disease is eligible, including COVID19! With a few exceptions, services are free of charge.
Next deadline for application: April 15th, 2020
For more info see www.transvac.org